Guangxi Liuzhou Pharm Co Ltd (603368) — Net Asset Momentum
Guangxi Liuzhou Pharm Co Ltd (603368) recorded a net asset momentum of 12.4% as of December 2024, with net assets of CN¥7.94 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See shareholders equity of Guangxi Liuzhou Pharm Co Ltd for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Guangxi Liuzhou Pharm Co Ltd Net Asset Momentum (2011–2024)
This chart tracks Guangxi Liuzhou Pharm Co Ltd's year-over-year net asset growth across 14 annual reporting periods from 2011 to 2024. The most recent momentum reading is +12.4%, with net assets of CN¥7.94 Billion CNY as of December 2024. For live market cap and overall valuation, see Guangxi Liuzhou Pharm Co Ltd market capitalisation.
Annual Net Asset History for Guangxi Liuzhou Pharm Co Ltd (2011–2024)
The table below shows the complete annual net asset history for Guangxi Liuzhou Pharm Co Ltd from 2011 to 2024, covering 14 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check 603368 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥7.94 Billion | CN¥21.27 Billion | CN¥13.33 Billion | ▲ +12.4% |
| 2023 | CN¥7.06 Billion | CN¥20.16 Billion | CN¥13.10 Billion | ▲ +11.0% |
| 2022 | CN¥6.37 Billion | CN¥18.61 Billion | CN¥12.24 Billion | ▲ +9.6% |
| 2021 | CN¥5.81 Billion | CN¥15.87 Billion | CN¥10.07 Billion | ▲ +6.6% |
| 2020 | CN¥5.44 Billion | CN¥14.81 Billion | CN¥9.36 Billion | ▲ +16.9% |
| 2019 | CN¥4.66 Billion | CN¥11.96 Billion | CN¥7.30 Billion | ▲ +15.1% |
| 2018 | CN¥4.05 Billion | CN¥9.77 Billion | CN¥5.73 Billion | ▲ +13.4% |
| 2017 | CN¥3.57 Billion | CN¥7.55 Billion | CN¥3.99 Billion | ▲ +10.2% |
| 2016 | CN¥3.24 Billion | CN¥6.28 Billion | CN¥3.04 Billion | ▲ +138.0% |
| 2015 | CN¥1.36 Billion | CN¥4.30 Billion | CN¥2.94 Billion | ▲ +15.9% |
| 2014 | CN¥1.17 Billion | CN¥3.74 Billion | CN¥2.56 Billion | ▲ +134.3% |
| 2013 | CN¥501.00 Million | CN¥2.70 Billion | CN¥2.20 Billion | ▲ +32.3% |
| 2012 | CN¥378.59 Million | CN¥2.03 Billion | CN¥1.65 Billion | ▲ +38.1% |
| 2011 | CN¥274.23 Million | CN¥1.57 Billion | CN¥1.30 Billion | — |